Skip to main content
OpenTrials
Completed

NCT Number: NCT02941211

Effectiveness and Safety Evaluation of Aqueduct -100 Device

Evaluation of efficacy and safety of using Aqueduct -100 - Cervical Dilator Device

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Hospital General Santa Maria del Puerto

Cadiz, 11500, Spain

About this study

There are predominantly two major dilatation techniques that are employed in dilating the cervix. The first technique uses expansible dry solid material, such as laminaria (seaweed) is inserted into the cervix in its dried stiff form. In the cervix it comes into contact with body fluids that cause the laminaria to swell and enlarge the cervical cavity. The second more widespread procedure, involves the use of series of solid, rod like instruments of graduated diameter used in serial fashion by the physician (Hegar dilators). The physician first inserts a rod like dilator and replaces it with the dilator of next higher diameter. This procedure continues until adequate dilatation occurs.

The Problem is that each of the above-mentioned methods has its shortcomings: the use of the laminaria method (rarely done) requires preliminary patient visit, for insertion of the laminaria rod and is extremely slow and typically involves often as much as 10-12 hours for a significant amount of dilatation to occur.

The use of rod-like instruments (Hegar) requires general or regional anesthesia, when local anesthetics are used, the patient nevertheless frequently experiences a great amount of discomfort from the procedure. The mechanical dilatation of the cervix demands a large amount of longitudinal force that may damage or even puncture the cervix and the uterus.

Aqueduct 100 is a catheter for use in dilating various body cavities and especially the human cervix. The device will enable continuous, fast and safe dilatation of the cervix to a pre-determined diameter as a pre-procedure to intrauterine surgeries.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Subjects, females, 18 years of age or older.
  • Subjects undergoing any process that requires dilation (intrauterine procedures)
  • Subjects willing to sign informed consent form.

Exclusion criteria

  • Subjects younger than 18 years of age
  • Subject with sex transmitted diseases, or with infectious diseases (HIV, HCV).
  • Subjects unwilling to sign the informed consent form.

Treatment and study plan

Aqueduct -100

Device

Primary outcomes

  1. Percentage of patients with dilation of cervix to the diameter needed to perform the intrauterine procedure using Aqueduct-100 device.

    Time frame: Through study completion, approximately 6 months

    The primary outcome of this study is to determine the efficacy of the Aqueduct-100 device to dilate the uterine cervices to the desired diameter.

Secondary outcomes

  1. Occurrence of Adverse Events

    Time frame: Through study completion, approximately 6 months

    Safety evaluation of using Aqueduct-100

Other outcomes

  1. Time frame required to reach desired cervical dilation from start time (insertion of device) to completion of dilation (removal of catheter)

    Time frame: Through study completion, approximately 6 months

    Duration of the dilation procedure.

  2. Measurement of physicians' overall satisfaction with the device through the use of a questionnaire

    Time frame: Through study completion, approximately 6 months

Sponsors and collaborators

Lead sponsor

Aqueduct Medical Ltd

Industry

Registry information

Important dates

Study start
2015
Primary completion
2015
Study completion
2015
First posted
Oct 21, 2016
Registry last updated
Oct 21, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.